New US Patent Granted to Sabinsa Sabinsa has been granted US patent #7,063,861, for Garcitrin®, a branded ingredient that offers effective. September 30, 2006 ForsLean® – New Study and NSF Certification A study published in the December 2005 Journal of the International Society of Sports Nutrition. January 31, 2006 Significant Study on ForsLean® Published in Obesity Research A study published in the peer reviewed medical journal "Obesity Research" reports that a twice-daily. October 31, 2005 Sabinsa Corporation Receives the 2005 Thomas Alva Edison Patent Award Sabinsa Corporation was awarded the Research & Development Council of New Jersey's 2005 Thomas Alva. October 31, 2005 NSF Certification for Selenium SeLECT® Selenium SeLECT® brand L-(+)-Selenomethionine ingredient from Sabinsa Corporation, has been certified for quality and content. September 30, 2005 Selenium SeLECT®: Exempt From European Union Food Supplements Directive On August 1, 2005 , the European Union is scheduled to ban approximately 300 supplement. May 31, 2005 Sabinsa Corporation Expands Manufacturing Facilities Sami Labs Limited, Sabinsa's research and manufacturing arm based in Bangalore, India, currently has four. April 30, 2005 Thomas Alva Edison Patent Award For ForsLean® A Sabinsa Corporation received the Thomas Alva Edison Patent Award for the year 2004. This. November 30, 2004 Safety of ForsLean® Affirmed By Independent Expert Review An independent review conducted by CANTOX Health Sciences International confirmed the safety of Sabinsa's ForsLean. November 30, 2004 New Clinical Trial Establishes The Safety and Efficacy of ForsLean® A double blind and randomized study was performed at the Shri C. B. Patel Research. July 31, 2004 Garcinia Double Salts Patent Concerns Are Unwarranted Sabinsa Corporation pioneered market development efforts for Garcinia cambogia extract (trademarked Citrin®) in the early. May 31, 2003 New Supercritical Extraction Facility Sabinsa Corporation, announced the completion of its new supercritical carbon dioxide extraction facility at Bangalore,. October 31, 2002 ZeaLutein® The Stabilized Lutein Composition ZeaLutein® is Sabinsa's new, patent pending, stabilized lutein composition consisting of a mixture of natural. February 28, 2002 Curcumin : A “Brain” Nutrient ? The diverse health benefits of the "curry spice" curcumin are well documented. Valued as an. January 31, 2002 Sabinsa’s ForsLean®–History, Cultivation, Safety, Health Benefits and Patents Sabinsa Corporation is proud to announce that ForsLean®, our unique product for promoting lean body. April 30, 2001 Sabinsa R & D: Focus on Analytical Method Validation Scientists at Sabinsa R & D continuously work on developing and validating efficient methods of. October 31, 1999 Sabinsa Receives Payment from Creative Compounds for ForsLean® Trademark Infringement An intellectual property battle lasting three years and reaching the US Supreme Court has ended. October 30, 1999 Patent on Forskohlin Assigned to Sabinsa Corporation Sabinsa® Corporation was recently assigned a patent (U.S. Patent #5,804,596, dated September 8, 1998) for. September 30, 1998 Dr. Vladimir Badmaev Invited to Speak at Columbia University Columbia University and its associated Medical School are well recognized for promoting complementary medicine. Recently,. October 31, 1997
